169.61
-3.33 (-1.93%)
| Penutupan Terdahulu | 172.94 |
| Jumlah Dagangan | 1,325,273 |
| Harga / Pendapatan (P/E Ke hadapan) | 60.24 |
| Harga / Jualan (P/S) | 11.91 |
| Harga / Buku (P/B) | 4.41 |
| Julat 52 Minggu |
| Margin Keuntungan | -3.53% |
| Margin Operasi (TTM) | 5.59% |
| EPS Cair (TTM) | -0.420 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 10.40% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 76.90% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 34.44% |
| Nisbah Semasa (MRQ) | 6.79 |
| Aliran Tunai Operasi (OCF TTM) | 145.69 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 183.66 M |
| Pulangan Atas Aset (ROA TTM) | 0.92% |
| Pulangan Atas Ekuiti (ROE TTM) | -1.16% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Bercampur | Bercampur |
| Medical Instruments & Supplies (Global) | Menaik | Bercampur | |
| Stok | Repligen Corporation | Bercampur | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | -5.0 |
| Volatiliti Harga | -4.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 0.5 |
| Purata | -0.89 |
|
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 6.41% |
| % Dimiliki oleh Institusi | 105.07% |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| HUGHES VIOLETTA | - | 170.02 | -277 | -47,096 |
| LOEILLOT OLIVIER | - | 168.61 | -5,877 | -990,698 |
| Jumlah Keseluruhan Kuantiti Bersih | -6,154 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -1,037,793 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 169.08 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| LOEILLOT OLIVIER | Pegawai | 04 Sep 2026 | Jual automatik (-) | 3,035 | 167.60 | 508,666 |
| LOEILLOT OLIVIER | Pegawai | 03 Sep 2026 | Dibuang (-) | 2,842 | 169.61 | 482,032 |
| HUGHES VIOLETTA | Pegawai | 01 Sep 2026 | Dibuang (-) | 277 | 170.02 | 47,096 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |